medroxyprogesterone acetate has been researched along with Dizzyness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehghani, A; Dehghani-Tafti, M; Karimi Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S | 1 |
| Darney, PD; Haider, S | 1 |
1 review(s) available for medroxyprogesterone acetate and Dizzyness
| Article | Year |
|---|---|
Injectable contraception.
Topics: Abdominal Pain; Anxiety; Contraceptive Agents, Female; Dizziness; Estradiol; Female; Headache; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Safety; Weight Gain | 2007 |
1 trial(s) available for medroxyprogesterone acetate and Dizzyness
| Article | Year |
|---|---|
Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Curettage; Dizziness; Endometrial Hyperplasia; Estradiol; Female; Fertility Preservation; Headache; Humans; Letrozole; Medroxyprogesterone Acetate; Middle Aged; Nitriles; Triazoles; Young Adult | 2013 |